Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19
Methadone maintenance treatment is a life-saving treatment for people with opioid use disorders (OUD). The coronavirus pandemic (COVID-19) has introduced many concerns surrounding access to opioid treatment. In March 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance allowing for the expansion of take-home methadone doses. We sought to describe changes to treatment experiences from the perspective of persons receiving methadone at outpatient treatment facilities for OUD.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Mary C. Figgatt, Zach Salazar, Elizabeth Day, Louise Vincent, Nabarun Dasgupta Source Type: research
More News: Addiction | Coronavirus | COVID-19 | Men | Methadone | Pandemics | Substance Abuse | Substance Abuse Disorders